Nobel Biocare Introduces GalvoSurge To Bring Groundbreaking Implant Care And Maintenance Solutions To The Market

At EuroPerio9 in Amsterdam, The Netherlands, Nobel Biocare is announcing a global exclusive partnership agreement with GalvoSurge Dental AG, a Swiss-based manufacturer of dental devices. The two companies intend to bring to market a new and innovative cleaning system for long-term implant maintenance on all major implant brands.

GalvoSurge® Dental Implant Cleaning System’s provides a unique protocol for decontamination of dental implants by removing the bacterial biofilm attachment directly from the implant surface. Most other methods available today attempt to clean implants from the outside in, which might be challenging due to the macro and micro geometry of the implant.

The GalvoSurge® Dental Implant Cleaning System is based on an electrolytic process that activates the production of hydrogen, which lifts off the bacterial film. The groundbreaking process aims to be atraumatic and pain free, only take 2-3 minutes per implant and maintain the implant surface integrity.

The GalvoSurge® Dental Implant Cleaning System has been under development since 2012 and will be available in 2019.

Nobel Biocare and GalvoSurge® are currently engaging with leading universities and researchers to establish treatment protocols for implant care and long-term maintenance.  

Mr. Hans Geiselhöringer, President, Nobel Biocare said, “With the increasing number of patients receiving dental implant treatment, the importance of long-term maintenance is becoming more important. Following an intensive collaboration with leading clinicians who developed GalvoSurge, customers of all major implant brands will soon have additional means to provide lasting implant care for their patients. With this new partnership, we are again at the forefront of innovation in the dental industry.”

GalvoSurge inventors and internationally renowned clinicians and researchers commented:

“This innovative technology is unique, fascinating and one step ahead of other technologies and protocols,” Dr. Markus Schlee explained.

“Finally, there is strong indications that we have developed a better cleaning technique for infected implant surfaces than commonly used methods,” Dr. Urs Brodbeck added.

Nobel Biocare President Mr. Hans Geiselhöringer with Dr. Markus Schlee, GalvoSurge CEO Roger Eberle and Dr. Urs Brodbeck (from left to right).

More information is available at and